Tapinarof(一种芳香烃受体配体)减轻甲状腺眼病中的成纤维细胞活化:新型治疗的意义
本研究探讨芳香烃受体(AHR)配体FICZ和tapinarof对甲状腺眼病(TED)眼眶成纤维细胞(OFs)中PDGFβ诱导活化的影响。结果显示PDGFβ促进TED OFs增殖、AKT磷酸化、TYMS表达及迁移,而FICZ或tapinarof可减弱这些效应,提示AHR与PDGF信号通路可能成为TED新治疗基础。
要点
- PDGFβ对TED OFs增殖的诱导显著强于非TED OFs。
- FICZ或tapinarof减弱PDGFβ依赖的增殖及下游信号。
- FICZ和tapinarof均减轻PDGFβ诱导的TED OF迁移。
核心结论
- PDGF信号导致TED OFs增殖和活化增加,AHR配体FICZ和tapinarof减轻PDGF诱导的效应,支持AHR和PDGF信号可能构成TED新治疗基础的概念。
研究设计与样本
- 取非TED和TED患者的眼眶成纤维细胞,用PDGFβ处理,加或不加AHR配体FICZ或tapinarof。
- 采用Alamar Blue法测细胞活力,BrdU法测细胞增殖,Western blotting和实时定量PCR测PDGF与AHR信号,划痕实验测OF迁移。
主要发现
- PDGFβ对TED OFs增殖的诱导显著强于对非TED OFs。
- PDGFβ增加AKT磷酸化和胸苷酸合成酶(TYMS)表达。
- FICZ或tapinarof减弱PDGFβ依赖的增殖和下游信号。
- TYMS及其他PDGF靶基因被PDGFβ上调,并被AHR激活降低。
- PDGFβ诱导TED OF迁移,FICZ和tapinarof均减弱此效应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In thyroid eye disease (TED), activation and proliferation of orbital fibroblasts (OFs) promotes remodeling and causes an increase in the volume of orbital tissue. Platelet-derived growth factors (PDGFs) are elevated in TED and promote OF activation. The aryl hydrocarbon receptor (AHR), a ligand activated nuclear receptor, is important in regulating OF activation. AHR ligands have been evaluated as therapeutic agents for inflammatory diseases. Here, we hypothesize that AHR ligands will block PDGF-induced signaling in TED OFs. METHODS: OFs from both non-TED and TED patients were treated with PDGFβ, with or without the AHR ligands 6-Formylindolo[3,2-b]carbazole (FICZ) or tapinarof. Cell viability was measured by the Alamar Blue assay. Cell proliferation was quantified using the BrdU assay. Cell lysates were collected and analyzed by Western blotting and real-time quantitative PCR (RT-qPCR) to measure PDGF and AHR signaling. Scratch assays were used to measure OF migration. RESULTS: PDGFβ induced proliferation in TED OFs significantly more than in non-TED OFs. Additionally, PDGFβ increased phosphorylation of AKT and expression of thymidylate synthase (TYMS). PDGFβ dependent proliferation and downstream signaling were attenuated by FICZ or tapinarof. TYMS and other PDGF target genes were upregulated by PDGFβ and reduced by AHR activation. PDGFβ induced TED OF migration while both FICZ and tapinarof diminished this effect. CONCLUSIONS: PDGF signaling led to increased proliferation and activation of TED OFs. Treatment of TED OFs with the AHR ligands, FICZ and tapinarof, mitigated PDGF induced effects. These studies support the concept that AHR and PDGF signaling could form the basis for new TED therapeutics.
引用
- Patrick CC, Roztocil E, Husain F, et al. Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel Therapy. Invest Ophthalmol Vis Sci. 2024. PMID: 39560627. doi:10.1167/iovs.65.13.40
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。